Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics

Cancer Cell. 2016 Sep 12;30(3):499-500. doi: 10.1016/j.ccell.2016.08.009. Epub 2016 Sep 12.
No abstract available

Publication types

  • Published Erratum